参考文献
[1] Tandukar S, Palevsky P M. Continuous Renal Replacement Therapy: Who, When, Why, and How.[J]. Chest, 2019,155(3):626-638.
[2] Khwaja A. KDIGO clinical practice guidelines for acute kidney injury.[J]. Nephron. Clinical practice, 2012,120(4):c179-c184.
[3] 叶然, 徐桂华, 陈璇, 等. 近三年国外护理教育研究热点的共词聚类分析[J]. 解放军护理杂志, 2012,29(20).
[4] 特殊血液净化技术应用于重症新型冠状病毒肺炎的专家共识[J]. 中华内科杂志, 2020,59(11):847-853.
[5] 冯璇璘, 邓磊, 张洋, 等. 连续性肾脏替代治疗中局部枸橼酸抗凝与全身肝素抗凝比较的Meta分析[J]. 中华危重病急救医学, 2020,32(08):982-987.
[6] Hetzel G R, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.[J]. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011,26(1):232-239.
[7] Moura E, de Brito G A, Alves J A, et al. Efficacy and Safety of Regional Anticoagulation with 4% Trisodium Citrate Versus Heparin in Extended Hemodialysis among Critical Patients with Cancer and Acute Kidney Injury.[J]. Blood purification, 2020:1-7.
[8] 姜变通, 张志刚, 靳修, 等. 无钙型局部枸橼酸抗凝用于连续性肾脏替代治疗的不同补钙途径对钙离子的影响:前瞻性随机交叉试验方案[J]. 中国组织工程研究, 2020,24(5):726-730.
[9] Brain M J, Roodenburg O S, McNeil J. Comparison of pre-filter and post-filter ionised calcium monitoring in continuous veno-venous hemodiafiltration (CVVHD-F) with citrate anti-coagulation.[J]. PloS one, 2017,12(12):e189745.
[10] 陈敏华, 呼邦传, 李茜, 等. 基于KDIGO分级的早期连续性肾脏替代治疗对重症急性肾损伤患者预后的影响[J]. 中华危重病急救医学, 2016,28(3):246-251.
[11] Hoste E A, Bagshaw S M, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.[J]. Intensive care medicine, 2015,41(8):1411-1423.
[12] Wald R, Bagshaw S M. The timing of renal replacement therapy initiation in acute kidney injury: is earlier truly better?*.[J]. Critical care medicine, 2014,42(8):1933-1934.
[13] 何青莲, 张凌, 付平, 等. CRRT介入时机与重症急性肾损伤患者预后关系的初步探讨[J]. 中国中西医结合肾病杂志, 2015,16(10).
[14] Yoon B R, Leem A Y, Park M S, et al. Optimal timing of initiating continuous renal replacement therapy in septic shock patients with acute kidney injury.[J]. Scientific reports, 2019,9(1):11981.
[15] Gaudry S, Hajage D, Benichou N, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials.[J]. Lancet (London, England), 2020,395(10235):1506-1515.
[16] Yang X M, Tu G W, Zheng J L, et al. A comparison of early versus late initiation of renal replacement therapy for acute kidney injury in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials.[J]. BMC nephrology, 2017,18(1):264.
[17] Luo X, Jiang L, Du B, et al. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients.[J]. Critical care (London, England), 2014,18(4):R144.
[18] 于洋, 许浩, 王翠翠, 等. 急性肾损伤患者连续肾脏替代治疗预后因素分析[J]. 中华急诊医学杂志, 2019,28(9):1078-1082.
[19] Skarupskien? I, Adukauskien? D, Kuzminskien? J, et al. Mortality prediction in patients with acute kidney injury requiring renal replacement therapy after cardiac surgery.[J]. Medicina (Kaunas, Lithuania), 2017,53(4):217-223.
[20] 周瑞祥, 翁方中, 戴伟, 等. 严重脓毒症早期应用连续性血液净化的时机 及其器官保护作用：一项随机双盲对照研究[J]. 中华危重病急救医学, 2016,28(3):241-245.
[21] Zha J, Li C, Cheng G, et al. The efficacy of renal replacement therapy strategies for septic-acute kidney injury: A PRISMA-compliant network meta-analysis.[J]. Medicine, 2019,98(16):e15257.
[22] 崔俊, 周峻峰, 万献尧. 脓毒症合并急性肾损伤患者连续性肾脏替代治疗剂量的选择[J]. 中华危重病急救医学, 2016,28(10).
[23] Lehner G F, Wiedermann C J, Joannidis M. High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis.[J]. Minerva anestesiologica, 2014,80(5):595-609.
[24] Joannes-Boyau O, Honoré P M, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial.[J]. Intensive care medicine, 2013,39(9):1535-1546.
[25] 刘琦, 王蕊花. 连续性肾脏替代治疗对抗菌药物剂量调整影响因素的研究进展[J]. 中华全科医师杂志, 2019,18(6):601-603.
[26] Roberts J A, Abdul-Aziz M H, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.[J]. The Lancet. Infectious diseases, 2014,14(6):498-509.
[27] Mueller B A, Smoyer W E. Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy.[J]. Clinical pharmacology and therapeutics, 2009,86(5):479-482.
[28] Vossen M G, Thalhammer F. Effects of renal replacement therapy on antimicrobial therapy[J]. Curr Clin Pharmacol, 2013,8(1):39-45.
[29] Charoensareerat T, Chaijamorn W, Boonpeng A, et al. Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study.[J]. Journal of critical care, 2019,54:77-82.
[30] Kempke A P, Leino A S, Daneshvar F, et al. Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies.[J]. Critical care research and practice, 2016,2016:3235765.
[31] Jamal J A, Economou C J, Lipman J, et al. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation[J]. Curr Opin Crit Care, 2012,18(5):460-471.
[32] Li A M, Gomersall C D, Choi G, et al. A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?[J]. The Journal of antimicrobial chemotherapy, 2009,64(5):929-937.
[33] 中国医师协会体外生命支持专业委员会. 成人体外膜氧合循环辅助专家共识[J]. 中华医学杂志, 2018,98(12):886-894.
[34] Kilburn D J, Shekar K, Fraser J F. The Complex Relationship of Extracorporeal Membrane Oxygenation and Acute Kidney Injury: Causation or Association?[J]. BioMed research international, 2016,2016:1094296.
[35] 血液净化急诊临床应用专家共识组. 血液净化急诊临床应用专家共识[J]. 中华急诊医学杂志, 2017,26(1):24-36.
[36] Lee C C, Chen S W, Cheng Y L, et al. The impact of CRRT modality in patients with AKI receiving ECMO: A nationwide registry study in Taiwan.[J]. Journal of critical care, 2020,57:102-107.
[37] Dado D N, Ainsworth C R, Thomas S B, et al. Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study.[J]. Blood purification, 2020,49(3):341-347.
[38] Symons J M, McMahon M W, Karamlou T, et al. Continuous renal replacement therapy with an automated monitor is superior to a free-flow system during extracorporeal life support.[J]. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2013,14(9):e404-e408.
[39] Yetimakman A F, Tanyildiz M, Kesici S, et al. Continuous Renal Replacement Therapy Applications on Extracorporeal Membrane Oxygenation Circuit.[J]. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2017,21(6):355-358.
[40] Seczyńska B, Królikowski W, Nowak I, et al. Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations.[J]. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2014,18(6):523-534.
